To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.

Sponsor

Latest action

Referred to the House Committee on Energy and Commerce.

Action timeline

Every recorded action on this bill, newest first. Stage badges color-code the legislative path.

Cosponsors (1)

Members who signed on to support this bill.